Cargando…

The development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy

Hypoxia is a prominent feature of malignant tumors and contributes to tumor proliferation, metastasis, and drug resistance in various solid tumors. Therefore, improving tumor oxygenation is crucial for curing tumors. To date, multiple strategies, including oxygen delivering and producing materials,...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Dandan, Zhang, Xing, Ma, Yichuan, Yang, Xinjian, Li, Zhenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791452/
https://www.ncbi.nlm.nih.gov/pubmed/36578285
http://dx.doi.org/10.1016/j.mtbio.2022.100517
_version_ 1784859409973772288
author Han, Dandan
Zhang, Xing
Ma, Yichuan
Yang, Xinjian
Li, Zhenhua
author_facet Han, Dandan
Zhang, Xing
Ma, Yichuan
Yang, Xinjian
Li, Zhenhua
author_sort Han, Dandan
collection PubMed
description Hypoxia is a prominent feature of malignant tumors and contributes to tumor proliferation, metastasis, and drug resistance in various solid tumors. Therefore, improving tumor oxygenation is crucial for curing tumors. To date, multiple strategies, including oxygen delivering and producing materials, have been designed to increase the oxygen concentration in hypoxic tumors. However, the unsustainable supply of oxygen is still the main obstacle, resulting in a suboptimal outcome in treating oxygen-deprived tumors. Thus, a sufficient oxygen supply is highly desirable in the treatment of hypoxic tumors. Photosynthesis, as the main source of oxygen in nature through the conversion of light energy into chemical energy and oxygen, has been widely studied in scientific research. Moreover, photosynthetic microorganisms have been increasingly applied in cancer therapy by increasing oxygenation, which improves the therapeutic effect of oxygen-consuming tumor therapeutic tools such as radiotherapy and photodynamic therapy. In this review, we summarize recent advances in the design and manufacture of live bacteria as oxygen shuttles for a new generation of hypoxic tumor treatment strategies. Finally, current challenges and future directions are also discussed for successfully addressing hypoxic tumor issues.
format Online
Article
Text
id pubmed-9791452
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97914522022-12-27 The development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy Han, Dandan Zhang, Xing Ma, Yichuan Yang, Xinjian Li, Zhenhua Mater Today Bio Review Article Hypoxia is a prominent feature of malignant tumors and contributes to tumor proliferation, metastasis, and drug resistance in various solid tumors. Therefore, improving tumor oxygenation is crucial for curing tumors. To date, multiple strategies, including oxygen delivering and producing materials, have been designed to increase the oxygen concentration in hypoxic tumors. However, the unsustainable supply of oxygen is still the main obstacle, resulting in a suboptimal outcome in treating oxygen-deprived tumors. Thus, a sufficient oxygen supply is highly desirable in the treatment of hypoxic tumors. Photosynthesis, as the main source of oxygen in nature through the conversion of light energy into chemical energy and oxygen, has been widely studied in scientific research. Moreover, photosynthetic microorganisms have been increasingly applied in cancer therapy by increasing oxygenation, which improves the therapeutic effect of oxygen-consuming tumor therapeutic tools such as radiotherapy and photodynamic therapy. In this review, we summarize recent advances in the design and manufacture of live bacteria as oxygen shuttles for a new generation of hypoxic tumor treatment strategies. Finally, current challenges and future directions are also discussed for successfully addressing hypoxic tumor issues. Elsevier 2022-12-10 /pmc/articles/PMC9791452/ /pubmed/36578285 http://dx.doi.org/10.1016/j.mtbio.2022.100517 Text en © 2022 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Han, Dandan
Zhang, Xing
Ma, Yichuan
Yang, Xinjian
Li, Zhenhua
The development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy
title The development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy
title_full The development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy
title_fullStr The development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy
title_full_unstemmed The development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy
title_short The development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy
title_sort development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791452/
https://www.ncbi.nlm.nih.gov/pubmed/36578285
http://dx.doi.org/10.1016/j.mtbio.2022.100517
work_keys_str_mv AT handandan thedevelopmentoflivemicroorganismbasedoxygenshuttlesforenhancedhypoxictumortherapy
AT zhangxing thedevelopmentoflivemicroorganismbasedoxygenshuttlesforenhancedhypoxictumortherapy
AT mayichuan thedevelopmentoflivemicroorganismbasedoxygenshuttlesforenhancedhypoxictumortherapy
AT yangxinjian thedevelopmentoflivemicroorganismbasedoxygenshuttlesforenhancedhypoxictumortherapy
AT lizhenhua thedevelopmentoflivemicroorganismbasedoxygenshuttlesforenhancedhypoxictumortherapy
AT handandan developmentoflivemicroorganismbasedoxygenshuttlesforenhancedhypoxictumortherapy
AT zhangxing developmentoflivemicroorganismbasedoxygenshuttlesforenhancedhypoxictumortherapy
AT mayichuan developmentoflivemicroorganismbasedoxygenshuttlesforenhancedhypoxictumortherapy
AT yangxinjian developmentoflivemicroorganismbasedoxygenshuttlesforenhancedhypoxictumortherapy
AT lizhenhua developmentoflivemicroorganismbasedoxygenshuttlesforenhancedhypoxictumortherapy